Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Clue Faces Competitor Scrutiny On Entry Into Birth Control App Space

Executive Summary

The US Food and Drug Administration has cleared Clue as the second app with a birth control indication to reach market – but the first company on the scene questions whether it's as effective as theirs.

You may also be interested in...



FDA Approves Birth Control Mobile App, Vaginal Ring

US FDA announced the approval of the first direct-to-consumer mobile medical app that can prevent pregnancy via fertility awareness tracking. The app, Natural Cycles, has been criticized in Europe after some users experienced unplanned pregnancies. On the same day, the agency approved the first contraceptive vaginal ring that can be reused for an entire year.

FDA’s 5 Steps To A Successful ASCA Pilot Submission

Sponsors participating in the US FDA’s Accreditation Scheme for Conformity Assessment pilot program should work closely with the lab and be prepared for a few extra steps in putting a submission together, agency staff say.

Biden Budget Proposal Includes $905M For Medical Supply Stockpile

The $1.5tn proposal includes limited information about the US FDA, but makes pandemic recovery a clear priority.

Topics

UsernamePublicRestriction

Register

MT143603

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel